Clinical Trials Directory

Trials / Terminated

TerminatedNCT02022072

Evaluation of Vital Capacity

Measurement of Assisted Vital Capacity to Appreciate the Level of Recruitment in Neuromuscular Diseases

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
66 (actual)
Sponsor
Centre d'Investigation Clinique et Technologique 805 · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Respiratory failure is the most common cause of death in neuromuscular diseases. The aim of this research is to evaluate the thoracopulmonary recruitment by comparison of inspiratory vital capacity (VC ins)and inspiratory/expiratory vital capacity (VC ins-ex) with the vital capacity (VC) according to pathology and severity of pulmonary damage of patients with neuromuscular diseases. The methodology consists in realize VC by support of inspiratory/expiratory pressures, while the patient is passive and realizing a maximal inspiratory/expiratory effort simultaneously, with the aid of mechanical insufflation/exsufflation device (Cough Assist®). The evaluation will last for 30 minutes and the non-inclusion criteria are those for an insufflation. The study hypothesis is that long term insufflation/exsufflation device use could improve thoracopulmonary mobility.

Conditions

Interventions

TypeNameDescription
DEVICEmeasures of assisted vital capacity by a mechanical insufflation/exsufflation (Cough Assist®)measures of assisted vital capacity by a mechanical insufflation/exsufflation (Cough Assist®)

Timeline

Start date
2013-05-01
Primary completion
2014-10-01
Completion
2015-04-01
First posted
2013-12-27
Last updated
2015-07-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02022072. Inclusion in this directory is not an endorsement.